Paper23946292
Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice.
Liu Y and 6 others. Am J Physiol Renal Physiol, 2013. Cited by 31 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice. Papers, record 23946292. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23946292
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiotensin II Type 1 Receptor Blockers | Major topic |
| Diabetic Nephropathies | Major topic |
| Losartan | Major topic |
| Oleic Acid | Major topic |
| Albuminuria | |
| Animals | |
| Diabetes Mellitus, Experimental | |
| Disease Models, Animal | |
| Drug Therapy, Combination | |
| Humans | |
| Mice | |
| Mice, Inbred C57BL | |
| Renin-Angiotensin System |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| DK-079162 | NIDDK NIH HHS | United States | R01DK079162 | PubMed and NIH |
Source NIH RePORTER
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 24049149 | Nitro-oleic acid is a novel anti-oxidative therapy for diabetic kidney disease. | https://conductscience.org/library/papers/24049149 |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12379575 | Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. | Circulation | 2002 | https://conductscience.org/library/papers/12379575 | PubMed |
| 2 | 18220690 | Role of inflammation in diabetic nephropathy. | Curr Diabetes Rev | 2008 | https://conductscience.org/library/papers/18220690 | PubMed |
| 3 | 15701701 | Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/15701701 | PubMed |
| 4 | 20671947 | Effects of Endogenous PPAR Agonist Nitro-Oleic Acid on Metabolic Syndrome in Obese Zucker Rats. | PPAR Res | 2010 | https://conductscience.org/library/papers/20671947 | PubMed |
| 5 | 22969168 | Inflammation in diabetic nephropathy. | Mediators Inflamm | 2012 | https://conductscience.org/library/papers/22969168 | PubMed |
| 6 | 9683226 | Pathogenesis, prevention, and treatment of diabetic nephropathy. | Lancet | 1998 | https://conductscience.org/library/papers/9683226 | PubMed |
| 7 | 16336586 | Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition. | Kidney Int Suppl | 2005 | https://conductscience.org/library/papers/16336586 | PubMed |
| 8 | 17928826 | Renoprotective role of the vitamin D receptor in diabetic nephropathy. | Kidney Int | 2008 | https://conductscience.org/library/papers/17928826 | PubMed |
| 9 | 10561134 | End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. | Am J Kidney Dis | 1999 | https://conductscience.org/library/papers/10561134 | PubMed |
| 10 | 17468336 | Nitro-linoleic acid inhibits vascular smooth muscle cell proliferation via the Keap1/Nrf2 signaling pathway. | Am J Physiol Heart Circ Physiol | 2007 | https://conductscience.org/library/papers/17468336 | PubMed |
| 11 | 12660331 | Amelioration of diabetic nephropathy in SPARC-null mice. | J Am Soc Nephrol | 2003 | https://conductscience.org/library/papers/12660331 | PubMed |
| 12 | 18753300 | Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injury. | Am J Physiol Renal Physiol | 2008 | https://conductscience.org/library/papers/18753300 | PubMed |
| 13 | 10440132 | Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli. | Diabetologia | 1999 | https://conductscience.org/library/papers/10440132 | PubMed |
| 14 | 12874441 | Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. | J Am Soc Nephrol | 2003 | https://conductscience.org/library/papers/12874441 | PubMed |
| 15 | 20182412 | Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes. | Kidney Int | 2010 | https://conductscience.org/library/papers/20182412 | PubMed |
| 16 | 20630933 | Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. | Am J Physiol Renal Physiol | 2010 | https://conductscience.org/library/papers/20630933 | PubMed |
| 17 | 19570878 | Heme oxygenase: the key to renal function regulation. | Am J Physiol Renal Physiol | 2009 | https://conductscience.org/library/papers/19570878 | PubMed |
| 18 | 17679649 | Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. | Hypertension | 2007 | https://conductscience.org/library/papers/17679649 | PubMed |
| 19 | 10652037 | Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. | Kidney Int | 2000 | https://conductscience.org/library/papers/10652037 | PubMed |
| 20 | 11565517 | Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. | N Engl J Med | 2001 | https://conductscience.org/library/papers/11565517 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41416442 | Advances regarding the mechanism of endoplasmic reticulum stress in diabetic kidney disease and pharmacological interventions (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/41416442 | PubMed |
| 40067577 | Canagliflozin Attenuates Podocyte Inflammatory Injury through Suppressing the TXNIP/NLRP3 Signaling Pathway in Diabetic Kidney Disease Mice. | Inflammation | 2025 | https://conductscience.org/library/papers/40067577 | PubMed |
| 39554401 | Exploring Hypertension: The Role of AT1 Receptors, Sartans, and Lipid Bilayers. | ACS Omega | 2024 | https://conductscience.org/library/papers/39554401 | PubMed |
| 38879114 | Adipocyte-specific Nrf2 deletion negates nitro-oleic acid benefits on glucose tolerance in diet-induced obesity. | Nitric Oxide | 2024 | https://conductscience.org/library/papers/38879114 | PubMed |
| 38179301 | Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/38179301 | PubMed |
| 34445757 | Nitro-Oleic Acid (NO2-OA) Improves Systolic Function in Dilated Cardiomyopathy by Attenuating Myocardial Fibrosis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445757 | PubMed |
| 33838229 | Olive oil-derived nitro-fatty acids: protection of mitochondrial function in non-alcoholic fatty liver disease. | J Nutr Biochem | 2021 | https://conductscience.org/library/papers/33838229 | PubMed |
| 32671602 | Suppression of Vascular Macrophage Activation by Nitro-Oleic Acid and its Implication for Abdominal Aortic Aneurysm Therapy. | Cardiovasc Drugs Ther | 2021 | https://conductscience.org/library/papers/32671602 | PubMed |
| 31196614 | Nitro-Fatty Acid Logistics: Formation, Biodistribution, Signaling, and Pharmacology. | Trends Endocrinol Metab | 2019 | https://conductscience.org/library/papers/31196614 | PubMed |
| 30769284 | Electrophilic nitro-oleic acid reverses obesity-induced hepatic steatosis. | Redox Biol | 2019 | https://conductscience.org/library/papers/30769284 | PubMed |
| 29760648 | Profile of Arachidonic Acid-Derived Inflammatory Markers and Its Modulation by Nitro-Oleic Acid in an Inherited Model of Amyotrophic Lateral Sclerosis. | Front Mol Neurosci | 2018 | https://conductscience.org/library/papers/29760648 | PubMed |
| 29605557 | Nitrolipids in kidney physiology and disease. | Nitric Oxide | 2018 | https://conductscience.org/library/papers/29605557 | PubMed |
| 29578057 | Inflammatory signaling and metabolic regulation by nitro-fatty acids. | Nitric Oxide | 2018 | https://conductscience.org/library/papers/29578057 | PubMed |
| 28146117 | Anti-Fibrotic Effect of Losartan, an Angiotensin II Receptor Blocker, Is Mediated through Inhibition of ER Stress via Up-Regulation of SIRT1, Followed by Induction of HO-1 and Thioredoxin. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28146117 | PubMed |
| 28054588 | Evaluation of 10-Nitro Oleic Acid Bio-Elimination in Rats and Humans. | Sci Rep | 2017 | https://conductscience.org/library/papers/28054588 | PubMed |
| 26719362 | Protection of nitro-fatty acid against kidney diseases. | Am J Physiol Renal Physiol | 2016 | https://conductscience.org/library/papers/26719362 | PubMed |
| 26709810 | Nitro-fatty acids in cardiovascular regulation and diseases: characteristics and molecular mechanisms. | Front Biosci (Landmark Ed) | 2016 | https://conductscience.org/library/papers/26709810 | PubMed |
| 26319242 | PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes. | J Am Soc Nephrol | 2016 | https://conductscience.org/library/papers/26319242 | PubMed |
| 26027855 | Nitric oxide in liver diseases. | Trends Pharmacol Sci | 2015 | https://conductscience.org/library/papers/26027855 | PubMed |
| 25861250 | Nitrooleic Acid Attenuates Lipid Metabolic Disorders and Liver Steatosis in DOCA-Salt Hypertensive Mice. | PPAR Res | 2015 | https://conductscience.org/library/papers/25861250 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23946292
GET https://conductscience.org/api/papers/v1/23946292/references?page=2